Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
ACI-35 VAC20121,
JNJ-64042056
Alzheimer's Disease (Phase 2/3) AC Immune SA, Janssen Tau Immunotherapy (active)